NCT01287845View on ClinicalTrials.gov

PET/CT (Positron Emission Tomography/Computed Tomography) Imaging for Safety and Tolerability and Diagnostic Performance of BAY1075553 in Patients With Prostate Cancer and Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

November 30, 2011

Conditions
Diagnostic Imaging
Interventions
DRUG

BAY1075553

Cancer patients, single intravenous bolus injection of 300 MBq BAY1075553 over 60 seconds on the treatment day 1

DRUG

BAY1075553

Healthy volunteers for dosimetry, single intravenous bolus injection of 300 MBq BAY1075553 over 60 seconds on the treatment day 1

Trial Locations (2)

4010

Linz

48109-0028

Ann Arbor

Sponsors
All Listed Sponsors
lead

Life Molecular Imaging SA

INDUSTRY